Back to Search Start Over

Reports Summarize Bronchitis Study Results from Tehran University of Medical Sciences [A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic...].

Source :
Stem Cell Week; 4/22/2024, p1777-1777, 1p
Publication Year :
2024

Abstract

A recent report from Tehran University of Medical Sciences discusses the complications associated with hematopoietic stem cell transplant (HSCT), including graft-versus-host disease. The report focuses on bronchiolitis obliterans syndrome (BOS), a pulmonary form of this syndrome, and the lack of a standard treatment for it. The researchers are conducting a clinical trial to evaluate the efficacy of tiotropium bromide, a bronchodilator, in patients with BOS. The study is ongoing, and the findings will be disseminated through peer-reviewed publications, conferences, and seminars. [Extracted from the article]

Details

Language :
English
ISSN :
15371360
Database :
Supplemental Index
Journal :
Stem Cell Week
Publication Type :
Periodical
Accession number :
176684055